Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
ICRA reported a 32% year-on-year rise in Q1 FY27 profit to ₹56.46 crore and a 31% revenue jump to ₹163.37 crore, aided by Ratings and Risk & Analytics.
Shanti Gold International has approved a ₹99.83 crore renounceable rights issue at ₹215 per share, with a record date of August 06, 2026 and subscription open August 14-21.
Kirloskar group companies reported mixed Q1 numbers for the Jun 25 quarter, with Kirloskar Brothers’ revenue falling QoQ, while Kirloskar Oil Engines and Kirloskar Industries posted varying trends.
GAIL’s Q1FY27 results showed a sharp sequential rebound, with net profit at Rs 4,292 crore, revenue at Rs 38,953 crore, and EBITDA margin expanding to 16.3%.
Aditya Birla Capital reported Q1 FY26 consolidated PAT of INR 835 crore with revenue rising 10% YoY, alongside higher lending portfolio and AUM across businesses.
Kajaria Ceramics has scheduled a board meeting and an earnings conference call on July 31, 2026, to review unaudited Q1 FY27 results, with dial-in details shared by Equirus.
GAIL has set a July 31, 2026 board meeting to approve Q1 FY27 unaudited results, with a trading window closure until August 2 and an expected earnings call.
Colinz Laboratories submitted FY26 audited-result newspaper clippings to BSE under SEBI Regulation 47(3), disclosing Q4 and full-year revenue and profit figures.
Shree Cement will announce Q1FY27 results on July 31, 2026, hold an ICICI Securities-hosted earnings call at 5 pm, and seek shareholder approval for a ₹70 final dividend.
Social media is debating whether to switch to FDs after a flat two-year Nifty, as historical studies show rebounds often followed similar stagnation phases.
Shadowfax reported Q1 FY27 profit of ₹65.40 crore on revenue from operations of ₹1,358.12 crore, with EBITDA margin at 6.8% and a July 31 results review scheduled.
Next Mediaworks reported a Q1 FY26 net loss of ₹1.17 crore on nil revenue, with losses narrowing from the previous quarter and year-ago period.
Turner Industries (BSE: 531164) reported a FY26 net loss of ₹2.06 lakh on zero operating revenue, while borrowings rose and the board approved audited results on May 28, 2026.
Strides Pharma reported Q1 FY27 revenue growth of 13% to ₹12,654 million, while net profit rose 56.7% aided by an exceptional gain; US revenue stayed steady.
Next Mediaworks has scheduled a July 31, 2026 board meeting to approve unaudited standalone results for the quarter ended June 30, 2026, with trading window closure until August 2.
Strides Pharma Science reported a 56.7% YoY jump in Q1 FY27 profit on an exceptional gain, while revenue rose 13% and freight inflation pressured margins.